HB5871 EngrossedEnrolled LRB096 18826 KTG 34212 b AN ACT concerning public aid.
HB5871 EngrossedEnrolled - 2 - LRB096 18826 KTG 34212 b (d) The Department shall not impose requirements for prior approval based on a preferred drug list for anti-retroviral, anti-hemophilic factor concentrates, or any atypical antipsychotics, conventional antipsychotics, or anticonvulsants used for the treatment of serious mental illnesses until 30 days after it has conducted a study of the impact of such requirements on patient care and submitted a report to the Speaker of the House of Representatives and the President of the Senate.